INDBInternet News Database 2.5 Updated 1 min ago · 293 sources Show or hide images Light or dark

Nanobody Shows Promise in Myasthenia Gravis

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab significantly...

Description from Medpagetoday.

Who is covering this

  1. Medpagetoday Center Factuality: Mostly factual US
    Nanobody Shows Promise in Myasthenia Gravis

    (MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab significantly...

Comments

Comments need JavaScript.